Panome Bio is a biomarker discovery platform offering biomarker analysis.
Panome Bio has raised $6.0M in total funding. The most recent round was Undisclosed. The last funding was announced in November 2024.
Panome Bio's investors include BioGeneration Ventures, Telegraph Hill Partners.
Panome Bio is headquartered in St Louis, United States.
Panome Bio is a biomarker discovery platform offering biomarker analysis.
Panome Bio is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Panome Bio — Funding & Investors." VCBacked, November 21, 2024, https://www.vcbacked.co/company/panome-bio. Accessed August 14, 2026.
VCBacked. (2024). Panome Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/panome-bio
{{cite web |title=Panome Bio — Funding & Investors |url=https://www.vcbacked.co/company/panome-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated